Ratio between PlGF and Flt-1 as a prognostic tool for cardiovascular diseases

The invention uses the significance of the biochemical markers PlGF and Flt-1 for risk stratification of people with a cardiovascular disease. The method involves the quantification and calculation of the ratio of PlGF / Flt-1 in a sample derived from the patient by means of a diagnostic kit.

Further Information: PDF

INNOVECTIS Gesellschaft für Innovations-Dienstleistungen mbH
Phone: +49 (0)69/798-49721

Contact
Dr. Otmar Schöller

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Red light therapy for repairing spinal cord injury passes milestone

Patients with spinal cord injury (SCI) could benefit from a future treatment to repair nerve connections using red and near-infrared light. The method, invented by scientists at the University of…

Insect research is revolutionized by technology

New technologies can revolutionise insect research and environmental monitoring. By using DNA, images, sounds and flight patterns analysed by AI, it’s possible to gain new insights into the world of…

X-ray satellite XMM-newton sees ‘space clover’ in a new light

Astronomers have discovered enormous circular radio features of unknown origin around some galaxies. Now, new observations of one dubbed the Cloverleaf suggest it was created by clashing groups of galaxies….

Partners & Sponsors